propranolol has been researched along with phenylbutazone in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (13.33) | 29.6817 |
| 2010's | 7 (23.33) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Bajusz, D; Balogh, GT; Dargó, G; Müller, J; Simon, K | 1 |
| Christensen, LK; Hansen, JM | 1 |
| Abdel-Wahed, S; el-Hawary, MB; el-Shiwy, T; Isaak, Z; Khayyal, MA | 1 |
| Kimelski, R | 1 |
| Kunze, KD; Porst, H; Tschöpel, L | 1 |
| Hanano, M; Iga, T; Sawada, Y; Sugiyama, Y | 1 |
| Michel, IM; Weinryb, I | 1 |
| Cockrill, BL; Platt, DS | 1 |
| Dinnendahl, V; Peters, HD; Schönhöfer, PS | 1 |
| Azevedo, AD; Freire-Maia, L; Lemos Fernandes, AD; Oliveira, SB | 1 |
| Kohút, A; Nicák, A | 1 |
| Kobayakawa, T | 1 |
| Jaques, R; Riesterer, L | 2 |
| Constantine, JW; Iorio, LC | 1 |
| Boyland, E; Grover, PL | 1 |
| D'Arcy, PF | 1 |
| Reid, AL | 1 |
| Baron, MG; Hetheridge, MJ; Jackson, SK; Jha, AN; Mintram, KS; Moody, AJ; Owen, SF; Purcell, WM | 1 |
5 review(s) available for propranolol and phenylbutazone
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Drug interactions with oral sulphonylurea hypoglycaemic drugs.
Topics: Allopurinol; Analgesics; Anticoagulants; Chloramphenicol; Chlorpropamide; Disulfiram; Drug Interactions; Ethanol; Glyburide; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Kinetics; Monoamine Oxidase Inhibitors; Novobiocin; Phenylbutazone; Phenytoin; Probenecid; Propranolol; Rifampin; Sulfonamides; Sulfonylurea Compounds; Tolbutamide | 1977 |
[Interaction between smoking and drugs].
Topics: Contraceptives, Oral; Humans; Kinetics; Lidocaine; Pharmaceutical Preparations; Phenylbutazone; Propranolol; Smoking; Theophylline | 1986 |
Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
Topics: Animals; Antipyrine; Barbiturates; Biological Availability; Chlorpromazine; Diazepam; Drug Evaluation; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Pentazocine; Pharmaceutical Preparations; Phenylbutazone; Phenytoin; Propranolol; Quinidine; Rats; Species Specificity; Tissue Distribution; Tolbutamide; Valproic Acid; Warfarin | 1985 |
Tobacco smoking and drugs: a clinically important interaction?
Topics: Acetaminophen; Animals; Dextropropoxyphene; Drug Interactions; Enzyme Induction; Glutethimide; Humans; Insulin; Lidocaine; Microsomes, Liver; Mixed Function Oxygenases; Pentazocine; Pharmaceutical Preparations; Phenacetin; Phenylbutazone; Propranolol; Smoking; Theophylline | 1984 |
25 other study(ies) available for propranolol and phenylbutazone
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design.
Topics: Binding Sites; Chemistry, Pharmaceutical; Drug Design; Humans; Hydrogen-Ion Concentration; Molecular Docking Simulation; Pharmaceutical Preparations; Protein Binding; Serum Albumin, Human; Spectrophotometry, Ultraviolet; Titrimetry | 2020 |
Effect of propranolol and phenylbutazone on the prostaglandin like activity of the rabbit's iris in endotoxin induced iritis.
Topics: Animals; Disease Models, Animal; Endotoxins; Female; Iris; Iritis; Male; Phenylbutazone; Propranolol; Prostaglandins; Rabbits | 1976 |
[Morphology and pathogenesis of liver injury produced by dihydralazine , propranolol and ketophenylbutazone].
Topics: Chemical and Drug Induced Liver Injury; Dihydralazine; Humans; Hydralazine; Immunity, Cellular; Liver Diseases; Phenylbutazone; Propranolol | 1985 |
Interactions of alpha-methylfluorene-2-acetic acid with adenylate cyclase.
Topics: Acetates; Adenosine Triphosphate; Adenylyl Cyclases; Animals; Anti-Inflammatory Agents; Cyclic AMP; Epinephrine; Fluorenes; Guinea Pigs; Histamine; Hydrazines; In Vitro Techniques; Indomethacin; Isomerism; Isoproterenol; Lung; Myocardium; Norepinephrine; Phenylbutazone; Phosphorus Radioisotopes; Propranolol; Prostaglandins; Pyridoxal Phosphate; Stimulation, Chemical; Tranylcypromine; Tritium | 1974 |
Biochemical changes in rat liver in response to treatment with drugs and other agents. I. Effects of anticonvulsant, anti-inflammatory, hypocholesterolaemic and adrenergic beta-blocking agents.
Topics: Acetanilides; Aminopyrine; Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Anticonvulsants; Barbiturates; Body Weight; Butyrates; Cytochromes; Cytoplasm; Electron Transport; Glucose-6-Phosphatase; Glucosephosphate Dehydrogenase; Glutamate Dehydrogenase; Indomethacin; L-Lactate Dehydrogenase; Liver; Male; Microsomes; Organ Size; Oxidoreductases; Phenobarbital; Phenylbutazone; Phenytoin; Phosphogluconate Dehydrogenase; Propranolol; Proteins; Rats; Sympatholytics | 1969 |
Effects of antilipolytic drugs on cyclic 3',5'-AMP dependent protein kinase.
Topics: Adipose Tissue; Animals; Cattle; Chloroquine; Cyclic AMP; Dose-Response Relationship, Drug; Flufenamic Acid; In Vitro Techniques; Insulin; Lipid Metabolism; Mefenamic Acid; Muscles; Nicotinic Acids; Norepinephrine; Phentolamine; Phenylbutazone; Phosphotransferases; Propranolol; Prostaglandins; Protein Kinase Inhibitors; Protein Kinases; Pyrazoles; Theophylline | 1973 |
Cardiovascular and respiratory changes during acute pulmonary edema produced by nephrotoxic serum in the rat.
Topics: Animals; Aspirin; Atropine; Basement Membrane; Hemodynamics; Immune Sera; Kidney; Kidney Cortex; Kidney Glomerulus; Lung; Microscopy, Electron; Phenoxybenzamine; Phenylbutazone; Physostigmine; Propranolol; Pulmonary Edema; Rabbits; Rats; Respiration; Time Factors; Vagotomy; Vagus Nerve | 1973 |
[Stomach ulcer induced by phenylbutazone and its course in adult rats].
Topics: Adrenal Glands; Adrenalectomy; Animals; Epinephrine; Metyrapone; Phenylbutazone; Promethazine; Propranolol; Rats; Stomach Ulcer | 1972 |
[Experimental study on drugs for the treatment of myocardial infarction].
Topics: Angiography; Animals; Benzyl Compounds; Body Weight; Carboxylic Acids; Dipyridamole; Disease Models, Animal; Electrocardiography; Glycols; Hydrocortisone; Indomethacin; Isoproterenol; Male; Microradiography; Microscopy, Electron; Myocardial Infarction; Myocardium; Organ Size; Phenoxybenzamine; Phenylbutazone; Propranolol; Pyridines; Rats; Rats, Inbred Strains; Thiophenes | 1972 |
The influence of anti-inflammatory drugs on the development of an experimental traumatic paw oedema in the rat.
Topics: Adrenal Glands; Adrenalectomy; Aminopyrine; Animals; Anti-Inflammatory Agents; Bromelains; Edema; Furans; Glycosides; Hindlimb; Hydrocortisone; Male; Phenylbutazone; Propranolol; Rats; Rutin; Salicylates; Sodium; Time Factors | 1970 |
Interference, by beta-adrenergic blocking agents, with the anti-inflammatory action of various drugs.
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Depression, Chemical; Exudates and Transudates; Hydrocortisone; Male; Phenylbutazone; Pleurisy; Propranolol; Rats; Sodium Salicylate; Sympatholytics; Turpentine | 1968 |
Bradykinin on isolated guinea-pig tracheal muscle.
Topics: Acetylcholine; Animals; Bradykinin; Guinea Pigs; Hypoxia; Muscle Contraction; Muscle, Smooth; Phenylbutazone; Propranolol; Salicylates; Trachea | 1969 |
The relationship between hepatic glutathione conjugation and BSP excretion and the effect of therapeutic agents.
Topics: Animals; Anthelmintics; Appetite Depressants; Benzofurans; Chlorphentermine; Diiodotyrosine; Glutathione; Humans; Insecticides; Iodipamide; Iodobenzenes; Iodopyracet; Iopanoic Acid; Liver; Liver Cirrhosis; Mestranol; Norethandrolone; Novobiocin; Phenindione; Phenylacetates; Phenylbutazone; Propranolol; Rabbits; Rats; Sulfobromophthalein; Transferases; Vasodilator Agents | 1967 |
Two bottles on the doorstep: a parable.
Topics: Aged; Drug Interactions; Education, Medical, Continuing; Furosemide; Geriatrics; Humans; Male; Nitrazepam; Phenylbutazone; Prochlorperazine; Promethazine; Propranolol; Tetracycline | 1983 |
Pharmaceutical Metabolism in Fish: Using a 3-D Hepatic In Vitro Model to Assess Clearance.
Topics: Animals; Atenolol; Biotransformation; Carbamazepine; Diazepam; Diclofenac; Drug Evaluation, Preclinical; Female; Kinetics; Liver; Metoprolol; Models, Animal; Oncorhynchus mykiss; Phenylbutazone; Propranolol; Tandem Mass Spectrometry; Water Pollutants, Chemical; Xenobiotics | 2017 |